Open access
Jul 2026
IL7-Receptor–Targeted CAR T-Cell Therapy for T-Cell Acute Lymphoblastic Leukemia
The authors propose IL7-Receptor (IL7R/CD127) as an alternative target for T-ALL and propose IL7-Receptor/CD127 CAR-T cells as an alternative target for T-ALL, showing the antitumor efficacy of IL7Rα/CD127 CAR-T cells against T-ALL in preclinical models.
H. Hocine, Undrakh Ganbaatar, Alfredo Amador-Molina et al.
· Nature Communications · 0 citations